Baseline left ventricular wall thickness after myocardial infarction predicts death or heart failure: Findings from the VALsartan in acute myocardial iNfarcTion trial (VALIANT)

被引：0
|
作者：
Kesari, S
Janardhanan, R
Pfeffer, MA
Skali, H
Anavekar, NS
McMurray, JJ
Velazquez, EJ
Kober, L
Arnold, JM
Warnica, JW
Ghali, JK
Solomon, SD
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Baker Heart Inst, Wynn Dept Metab Cardiol, Melbourne, Vic, Australia
[3] Western Infirm & Associated Hosp, Glasgow, Lanark, Scotland
[4] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA
[5] Rigshosp, DK-2100 Copenhagen, Denmark
[6] Univ Western Ontario, London, ON, Canada
[7] Univ Calgary, Calgary, AB, Canada
[8] Cardiac Ctr Louisiana, Shreveport, LA USA
[9] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
CIRCULATION | 2005年 / 112卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2508
引用
下载
收藏
页码：U588 / U588
页数：1
相关论文
共 50 条
  • [1] Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: The VALsartan In Acute myocardial iNfarcTion Trial (VALIANT)
    Shamshad, Faisal
    Kenchaiah, Satish
    Finn, Peter V.
    Soler-Soler, Jordi
    McMurray, John J. V.
    Velazquez, Eric J.
    Maggioni, Aldo P.
    Califf, Robert M.
    Swedberg, Karl
    Kober, Lars
    Belenkov, Yuri
    Varshavsky, Sergei
    Pfeffer, Marc A.
    Solomon, Scott D.
    AMERICAN HEART JOURNAL, 2010, 160 (01) : 145 - 151
  • [2] Extent of coronary artery disease and cardiovascular outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: Findings from the VALsartan in acute myocardial iNfarcTion trial (VALIANT)
    Janardhanan, R
    Kenchaiah, S
    Pfeffer, MA
    McMurray, JJ
    Velazquez, EJ
    Califf, RM
    Weaver, WD
    White, H
    Park, Y
    Finn, PV
    Solomon, SD
    CIRCULATION, 2005, 112 (17) : U568 - U568
  • [3] VALIANT (VALsartan in acute myocardial iNfarcTion) trial
    Maggioni, AP
    Fabbri, G
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (03) : 507 - 512
  • [4] VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context
    Velazquez, EJ
    Pfeffer, MA
    McMurray, JV
    Maggioni, AP
    Rouleau, JL
    Van de Werf, F
    Kober, L
    White, HD
    Swedberg, K
    Leimberger, JD
    Gallo, P
    Sellers, MA
    Edwards, S
    Henis, M
    Califf, RM
    EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (04) : 537 - 544
  • [5] Geographic variation in the treatment of acute myocardial infarction in the VALsartan in acute myocardial iNfarcTion (VALIANT) trial
    Reed, Shelby D.
    McMurray, John J. V.
    Velazquez, Eric J.
    Schulman, Kevin A.
    Califf, Robert M.
    Kober, Lars
    Maggioni, Aldo P.
    Van de Werf, Frans
    White, Harvey D.
    Diaz, Rafael
    Mareev, Viatcheslav
    Murin, Jan
    AMERICAN HEART JOURNAL, 2006, 152 (03) : 500 - 508
  • [6] Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction - Results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)
    White, HD
    Aylward, PEG
    Huang, Z
    Dalby, AJ
    Weaver, WD
    Barvik, S
    Marin-Neto, JA
    Murin, J
    Nordlander, RO
    van Gilst, WH
    Zannad, F
    McMurray, JJV
    Califf, RM
    Pfeffer, MA
    CIRCULATION, 2005, 112 (22) : 3391 - 3399
  • [7] The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction - An analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)
    McMurray, J
    Solomon, S
    Pieper, K
    Reed, S
    Rouleau, J
    Velazquez, E
    White, H
    Howlett, J
    Swedberg, K
    Maggioni, A
    Kober, L
    Van de Werf, F
    Calif, R
    Pfeiffer, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 726 - 733
  • [8] The effect of valsartan, captopril, or both on atherosclerotic events after myocardial infarction: an analysis of the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial
    McMurray, J. J. V.
    Solomon, S.
    Reed, S.
    Velazquez, E.
    White, H.
    Howlett, J.
    Maggioni, A.
    Kober, L.
    EUROPEAN HEART JOURNAL, 2005, 26 : 12 - 12
  • [9] Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction
    Bissessor, Naylin
    White, Harvey
    VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (04) : 425 - 430
  • [10] High-risk myocardial infarction in the young: The VALsartan In Acute myocardial iNfarcTion (VALIANT) trial
    Anderson, Rachel E.
    Pfeffer, Marc A.
    Thune, Jens Jakob
    McMurray, John J. V.
    Califf, Robert M.
    Velazquez, Eric
    White, Harvey D.
    Rouleau, Jean L.
    Skali, Hicham
    Maggioni, Aldo
    Solomon, Scott D.
    AMERICAN HEART JOURNAL, 2008, 155 (04) : 706 - 711
12345